These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3927916)

  • 21. Blood-brain transfer and metabolism of 6-[18F]fluoro-L-dopa in rat.
    Reith J; Dyve S; Kuwabara H; Guttman M; Diksic M; Gjedde A
    J Cereb Blood Flow Metab; 1990 Sep; 10(5):707-19. PubMed ID: 2117017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. L-6-[18F]fluoro-dopa metabolism in monkeys and humans: biochemical parameters for the formulation of tracer kinetic models with positron emission tomography.
    Melega WP; Grafton ST; Huang SC; Satyamurthy N; Phelps ME; Barrio JR
    J Cereb Blood Flow Metab; 1991 Nov; 11(6):890-7. PubMed ID: 1939384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetics of in vitro decarboxylation and the in vivo metabolism of 2-18F- and 6-18F-fluorodopa in the hooded rat.
    Cumming P; Häusser M; Martin WR; Grierson J; Adam MJ; Ruth TJ; McGeer EG
    Biochem Pharmacol; 1988 Jan; 37(2):247-50. PubMed ID: 3124856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BIA 3-202, a novel catechol-O-methyltransferase inhibitor, reduces the peripheral O-methylation of L-DOPA and enhances its availability to the brain.
    Parada A; Soares-da-Silva P
    Pharmacology; 2003 May; 68(1):29-37. PubMed ID: 12660477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Robotic synthesis of 6-[18F]fluoro-L-dopa.
    Chang CW; Wang HE; Lin HM; Chtsai CS; Chen JB; Liu RS
    Nucl Med Commun; 2000 Sep; 21(9):799-802. PubMed ID: 11065151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of plasma 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine ([18F]Fdopa) in humans.
    Cumming P; Léger GC; Kuwabara H; Gjedde A
    J Cereb Blood Flow Metab; 1993 Jul; 13(4):668-75. PubMed ID: 8314919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of carbidopa on the metabolism of 6-[18F]fluoro-L-dopa in rats, monkeys and humans.
    Melega WP; Hoffman JM; Luxen A; Nissenson CH; Phelps ME; Barrio JR
    Life Sci; 1990; 47(2):149-57. PubMed ID: 2117691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of response to COMT inhibition in FDOPA PET in advanced Parkinson's disease requires prolonged imaging.
    Ruottinen HM; Niinivirta M; Bergman J; Oikonen V; Solin O; Eskola O; Eronen E; Sonninen P; Rinne UK
    Synapse; 2001 Apr; 40(1):19-26. PubMed ID: 11170218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Graphical analysis of 6-fluoro-L-dopa trapping: effect of inhibition of catechol-O-methyltransferase.
    Holden JE; Doudet D; Endres CJ; Chan GL; Morrison KS; Vingerhoets FJ; Snow BJ; Pate BD; Sossi V; Buckley KR; Ruth TJ
    J Nucl Med; 1997 Oct; 38(10):1568-74. PubMed ID: 9379194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of carbidopa administration on 6-[18F]fluoro-L-dopa kinetics in positron emission tomography.
    Hoffman JM; Melega WP; Hawk TC; Grafton SC; Luxen A; Mahoney DK; Barrio JR; Huang SC; Mazziotta JC; Phelps ME
    J Nucl Med; 1992 Aug; 33(8):1472-7. PubMed ID: 1634937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (-)-epigallocatechin gallate.
    Lu H; Meng X; Yang CS
    Drug Metab Dispos; 2003 May; 31(5):572-9. PubMed ID: 12695345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On the accuracy of an [18F]FDOPA compartmental model: evidence for vesicular storage of [18F]fluorodopamine in vivo.
    Deep P; Gjedde A; Cumming P
    J Neurosci Methods; 1997 Oct; 76(2):157-65. PubMed ID: 9350967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 18F-dopa PET evidence that tolcapone acts as a central COMT inhibitor in Parkinson's disease.
    Ceravolo R; Piccini P; Bailey DL; Jorga KM; Bryson H; Brooks DJ
    Synapse; 2002 Mar; 43(3):201-7. PubMed ID: 11793426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebral 6-[(18)F]fluoro-L-DOPA (FDOPA) metabolism in pig studied by positron emission tomography.
    Danielsen EH; Smith DF; Gee AD; Venkatachalam TK; Hansen SB; Hermansen F; Gjedde A; Cumming P
    Synapse; 1999 Sep; 33(4):247-58. PubMed ID: 10421705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High yield synthesis of 6-[18F]fluoro-L-dopa by regioselective fluorination of protected L-dopa with [18F]acetylhypofluorite.
    Chaly T; Diksic M
    J Nucl Med; 1986 Dec; 27(12):1896-901. PubMed ID: 3097278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular mechanisms controlling the rate and specificity of catechol O-methylation by human soluble catechol O-methyltransferase.
    Lautala P; Ulmanen I; Taskinen J
    Mol Pharmacol; 2001 Feb; 59(2):393-402. PubMed ID: 11160877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strong inhibitory effects of common tea catechins and bioflavonoids on the O-methylation of catechol estrogens catalyzed by human liver cytosolic catechol-O-methyltransferase.
    Nagai M; Conney AH; Zhu BT
    Drug Metab Dispos; 2004 May; 32(5):497-504. PubMed ID: 15100171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetics of rat brain and liver solubilized membrane-bound catechol-O-methyltransferase.
    Bonifácio MJ; Vieira-Coelho MA; Borges N; Soares-da-Silva P
    Arch Biochem Biophys; 2000 Dec; 384(2):361-7. PubMed ID: 11368324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formation of 3-hydroxy-4-methoxyphenylalanine from 3,4-dihydroxyphenylalanine by rat liver homogenate.
    Ishimitsu T; Hirose S
    Chem Pharm Bull (Tokyo); 1980 Jul; 28(7):2272-3. PubMed ID: 6778621
    [No Abstract]   [Full Text] [Related]  

  • 40. The influx of neutral amino acids into the porcine brain during development: a positron emission tomography study.
    Brust P; Vorwieger G; Walter B; Füchtner F; Stark H; Kuwabara H; Herzau M; Opfermann T; Steinbach J; Ganapathy V; Bauer R
    Brain Res Dev Brain Res; 2004 Sep; 152(2):241-53. PubMed ID: 15351512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.